6 insiders reported 12 Form 4 transactions for Eloxx Pharmaceuticals, Inc. (ELOX) over the past 18 months (most recent 2026-06-05). Recent activity: Domicilium Real Estate Fund III LP (Insider) Sell 113,636 shares, Coastlands Capital LP (Insider) Sell 1.2M shares, Rubin Steven D (Director) Buy 1,875 shares, Walts Alan Edmund (Director) Buy 1,875 shares, Aggarwal Sumit (President and CEO) Buy 196,880 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-05 | Domicilium Real Estate Fund III LP | Insider | Sell | 113,636 | $0 |
| 2026-05-29 | Coastlands Capital LP | Insider | Sell | 1.2M | $0 |
| 2026-05-08 | Rubin Steven D | Director | Buy | 1,875 | $0 |
| 2026-05-08 | Walts Alan Edmund | Director | Buy | 1,875 | $0 |
| 2026-05-08 | Aggarwal Sumit | President and CEO | Buy | 196,880 | $20 |
| 2026-05-08 | Aggarwal Sumit | President and CEO | Buy | 1.0M | $0 |
| 2026-05-08 | Aggarwal Sumit | President and CEO | Buy | 15,000 | $0 |
| 2026-05-08 | Aggarwal Sumit | President and CEO | Buy | 260,946 | $39,142 |
| 2025-01-28 | Walts Alan Edmund | Director | Buy | 3,750 | $0 |
| 2025-01-28 | Rubin Steven D | Director | Buy | 3,750 | $0 |
| 2025-01-28 | Aggarwal Sumit | Director | Buy | 30,000 | $0 |
| 2025-01-28 | Androski Lindsay | Director | Buy | 3,750 | $0 |
Source: SEC Form 4 filings · as of 2026-06-05
